Heartflow, Inc.’s (NASDAQ:HTFL) Lock-Up Period Will Expire on February 4th

Heartflow’s (NASDAQ:HTFL) lock-up period is set to end on Wednesday, February 4th. Heartflow had issued 16,666,667 shares in its initial public offering on August 8th. The total size of the offering was $316,666,673 based on an initial share price of $19.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Wells Fargo & Company started coverage on Heartflow in a research note on Wednesday. They issued an “overweight” rating and a $38.00 target price on the stock. Canaccord Genuity Group boosted their price objective on shares of Heartflow from $39.00 to $40.00 and gave the stock a “buy” rating in a research report on Thursday, November 13th. Stifel Nicolaus raised their target price on shares of Heartflow from $35.00 to $40.00 and gave the company a “buy” rating in a research report on Thursday, November 13th. JPMorgan Chase & Co. boosted their price target on shares of Heartflow from $36.00 to $40.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Heartflow in a report on Monday, December 29th. Five analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $38.50.

Heartflow Stock Performance

HTFL opened at $30.82 on Friday. Heartflow has a 12-month low of $25.38 and a 12-month high of $41.22. The company has a 50 day simple moving average of $30.73. The firm has a market capitalization of $2.62 billion and a PE ratio of -17.03.

Insider Activity at Heartflow

In other news, Director Jeffrey C. Lightcap bought 40,000 shares of the firm’s stock in a transaction dated Tuesday, December 16th. The shares were bought at an average price of $26.34 per share, with a total value of $1,053,600.00. Following the completion of the transaction, the director owned 40,000 shares of the company’s stock, valued at $1,053,600. This trade represents a ? increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in HTFL. TFC Financial Management Inc. bought a new stake in shares of Heartflow in the third quarter valued at about $40,000. Emerald Mutual Fund Advisers Trust bought a new position in Heartflow during the third quarter worth about $4,418,000. TrueMark Investments LLC bought a new stake in Heartflow in the 3rd quarter valued at about $918,000. Baillie Gifford & Co. acquired a new position in shares of Heartflow during the 3rd quarter worth approximately $101,182,000. Finally, Y Intercept Hong Kong Ltd bought a new position in shares of Heartflow during the third quarter worth approximately $234,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.